Carl H. June, MD
Affiliations: | Pathology | University of Pennsylvania, Philadelphia, PA, United States |
Google:
"Carl June"Children
Sign in to add trainee| Luk H. Vandenberghe | grad student | Penn | |
| Marcela V. Maus | grad student | 2003 | Penn |
| Megan M. Suhoski | grad student | 2008 | Penn |
| Tyler Reich | research scientist | 2014-2016 | Penn (Chemistry Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Feng Z, He X, Zhang X, et al. (2024) Author Correction: Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissues. Nature Cancer |
| Tilsed CM, Sadiq BA, Papp TE, et al. (2024) IL7 increases targeted lipid nanoparticle-mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translation. Proceedings of the National Academy of Sciences of the United States of America. 121: e2319856121 |
| Bagley SJ, Logun M, Fraietta JA, et al. (2024) Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results. Nature Medicine |
| Metzloff AE, Padilla MS, Gong N, et al. (2024) Antigen Presenting Cell Mimetic Lipid Nanoparticles for Rapid mRNA CAR T Cell Cancer Immunotherapy. Advanced Materials (Deerfield Beach, Fla.). e2313226 |
| Roselle C, Horikawa I, Chen L, et al. (2024) Enhancing chimeric antigen receptor T cell therapy by modulating the p53 signaling network with Δ133p53α. Proceedings of the National Academy of Sciences of the United States of America. 121: e2317735121 |
| Myers RM, Devine KJ, Li Y, et al. (2024) Reinfusion of CD19 CAR T Cells for Relapse Prevention and Treatment in Children with Acute Lymphoblastic Leukemia. Blood Advances |
| Gong N, Han X, Xue L, et al. (2024) Small-molecule-mediated control of the anti-tumour activity and off-tumour toxicity of a supramolecular bispecific T cell engager. Nature Biomedical Engineering |
| Song DG, Ye Q, Carpenito C, et al. (2024) Editor's Note: In Vivo Persistence, Tumor Localization, and Antitumor Activity of CAR-Engineered T Cells Is Enhanced by Costimulatory Signaling through CD137 (4-1BB). Cancer Research. 84: 639 |
| Mai D, Boyce T, Mehta A, et al. (2024) ZFP36 disruption is insufficient to enhance the function of mesothelin-targeting human CAR-T cells. Scientific Reports. 14: 3113 |
| Vittayawacharin P, Kongtim P, Chu Y, et al. (2024) Adoptive cellular therapy after hematopoietic stem cell transplantation. American Journal of Hematology |